Ben Atkins | VP Communications and Investor Relations |
Roger Crystal | President, Chief Executive Officer |
David O’Toole | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Carl Byrnes | Northland Capital Markets |
Trevor Allred | Oppenheimer |
Greetings, and welcome to Opiant Pharmaceuticals Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Ben Atkins, Vice President of Communications and Investor Relations.